Pathstone Family Office’s Kite Pharma, Inc. KITE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q3
Sell
-1,500
Closed -$156K 382
2017
Q2
$156K Buy
1,500
+750
+100% +$78K 0.07% 120
2017
Q1
$59K Buy
+750
New +$59K 0.03% 169
2016
Q4
Sell
-422
Closed -$74K 233
2016
Q3
$74K Hold
422
0.08% 49
2016
Q2
$21K Buy
422
+100
+31% +$4.98K 0.02% 88
2016
Q1
$15K Buy
+322
New +$15K 0.03% 87